Exact Mass: 455.22088040000006
Exact Mass Matches: 455.22088040000006
Found 181 metabolites which its exact mass value is equals to given mass value 455.22088040000006,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lacidipine
C26H33NO6 (455.23077580000006)
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Erythroskyrin
C26H33NO6 (455.23077580000006)
Erythroskyrin is a mycotoxin produced by the common food storage mould Penicillium islandicu
Lacidipine
C26H33NO6 (455.23077580000006)
2,6-dimethyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester
C26H33NO6 (455.23077580000006)
3-[11-(3-Hydroxy-5-methyl-hexahydro-furo[3,2-b]furan-2-yl)-undeca-2,4,6,8,10-pentaenoyl]-5-isopropyl-1-methyl-pyrrolidin-2,4-dion|3-[11-(3-hydroxy-5-methyl-hexahydro-furo[3,2-b]furan-2-yl)-undeca-2,4,6,8,10-pentaenoyl]-5-isopropyl-1-methyl-pyrrolidine-2,4-dione
C26H33NO6 (455.23077580000006)
Ala His Gln Thr
Ala His Thr Gln
Ala Gln His Thr
Ala Gln Thr His
Ala Thr His Gln
Ala Thr Gln His
Asp Gly His Lys
Asp Gly Lys His
Asp His Gly Lys
Asp His Lys Gly
Asp Lys Gly His
Asp Lys His Gly
Gly Asp His Lys
Gly Asp Lys His
Gly His Asp Lys
Gly His Lys Asp
Gly His Arg Ser
Gly His Ser Arg
Gly Lys Asp His
Gly Lys His Asp
Gly Pro Pro Trp
C23H29N5O5 (455.21685840000004)
Gly Pro Trp Pro
C23H29N5O5 (455.21685840000004)
Gly Arg His Ser
Gly Arg Ser His
Gly Ser His Arg
Gly Ser Arg His
Gly Trp Pro Pro
C23H29N5O5 (455.21685840000004)
His Ala Gln Thr
His Ala Thr Gln
His Asp Gly Lys
His Asp Lys Gly
His Gly Asp Lys
His Gly Lys Asp
His Gly Arg Ser
His Gly Ser Arg
His Lys Asp Gly
His Lys Gly Asp
His Asn Ser Val
His Asn Val Ser
His Gln Ala Thr
His Gln Thr Ala
His Arg Gly Ser
His Arg Ser Gly
His Ser Gly Arg
His Ser Asn Val
His Ser Arg Gly
His Ser Val Asn
His Thr Ala Gln
His Thr Gln Ala
His Val Asn Ser
His Val Ser Asn
Lys Asp Gly His
Lys Asp His Gly
Lys Gly Asp His
Lys Gly His Asp
Lys His Asp Gly
Lys His Gly Asp
Asn His Ser Val
Asn His Val Ser
Asn Ser His Val
Asn Ser Val His
Asn Val His Ser
Asn Val Ser His
Pro Gly Pro Trp
C23H29N5O5 (455.21685840000004)
Pro Gly Trp Pro
C23H29N5O5 (455.21685840000004)
Pro Pro Gly Trp
C23H29N5O5 (455.21685840000004)
Pro Pro Trp Gly
C23H29N5O5 (455.21685840000004)
Pro Trp Gly Pro
C23H29N5O5 (455.21685840000004)
Pro Trp Pro Gly
C23H29N5O5 (455.21685840000004)
Gln Ala His Thr
Gln Ala Thr His
Gln His Ala Thr
Gln His Thr Ala
Gln Thr Ala His
Gln Thr His Ala
Arg Gly His Ser
Arg Gly Ser His
Arg His Gly Ser
Arg His Ser Gly
Arg Ser Gly His
Arg Ser His Gly
Ser Gly His Arg
Ser Gly Arg His
Ser His Gly Arg
Ser His Asn Val
Ser His Arg Gly
Ser His Val Asn
Ser Asn His Val
Ser Asn Val His
Ser Arg Gly His
Ser Arg His Gly
Ser Val His Asn
Ser Val Asn His
Thr Ala His Gln
Thr Ala Gln His
Thr His Ala Gln
Thr His Gln Ala
Thr Gln Ala His
Thr Gln His Ala
Val His Asn Ser
Val His Ser Asn
Val Asn His Ser
Val Asn Ser His
Val Ser His Asn
Val Ser Asn His
Trp Gly Pro Pro
C23H29N5O5 (455.21685840000004)
Trp Pro Gly Pro
C23H29N5O5 (455.21685840000004)
Trp Pro Pro Gly
C23H29N5O5 (455.21685840000004)
Erythroskyrin
C26H33NO6 (455.23077580000006)
4-[3-[4,7-dimethoxy-6-(2-piperidin-1-ylethoxy)-1-benzofuran-5-yl]-3-hydroxypropyl]phenol
C26H33NO6 (455.23077580000006)
(2R,3R)-N^1^-[(1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl]-N^4^-hydroxy-2-(2-methylpropyl)-3-{[(1,3-thiazol-2-ylcarbonyl)amino]methyl}butanediamide
C20H33N5O5S (455.2202288000001)
Ro 25-6981 maleate
C26H33NO6 (455.23077580000006)
Ro 25-6981 Maleate is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 Maleat shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 Maleate has the potential for the research of parkinson's disease (PD)[1][2][3].
ethyl 4-[3-oxo-3-[(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)amino]propanoyl]piperazine-1-carboxylate
C23H29N5O5 (455.21685840000004)
4-[4-[(1R,5S)-3-(1,3-benzodioxol-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
C28H29N3O3 (455.22088040000006)
(3R,6aS,8S,10aS)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N,N-dimethyl-4-[3-[(E)-prop-1-enyl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C25H33N3O3S (455.22425080000005)
(3R,6aS,8R,10aS)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
3-fluoro-N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
(3S,6aR,8S,10aR)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
(2S,3S,3aR,9bR)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-3-(hydroxymethyl)-1-methyl-7-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C28H29N3O3 (455.22088040000006)
3-fluoro-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
(3R,6aR,8S,10aR)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
(3S,6aR,8R,10aR)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-N-[(1S)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C28H29N3O3 (455.22088040000006)
(2R,3R,3aS,9bS)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-3-(hydroxymethyl)-1-methyl-7-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C28H29N3O3 (455.22088040000006)
(2R,3R,3aS,9bS)-1-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-N-(4-phenylphenyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C28H29N3O3 (455.22088040000006)
3-[4-[(1S,5R)-6-(1,3-benzodioxol-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
C28H29N3O3 (455.22088040000006)
diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-3,4-dihydropyridine-3,5-dicarboxylate
C26H33NO6 (455.23077580000006)
2-Amino-3-[hydroxy-(2-hydroxy-3-tridecanoyloxypropoxy)phosphoryl]oxypropanoic acid
C19H38NO9P (455.2284068000001)
1-tridecanoyl-sn-glycero-3-phosphoserine
C19H38NO9P (455.2284068000001)
CMF019
C25H33N3O3S (455.22425080000005)
CMF019 is a potent and small molecule agonist at Apelin receptor (APJ) with G protein bias. CMF019 binds to APJ with pKi values of 8.58, 8.49 and 8.71 for human, rat, and mouse, respectively. CMF019 mimics the beneficial cardiovascular actions of apelin in rodents[1]. Apelin receptor (APJ) is a G protein-coupled receptor (GPCR) activated by the endogenous peptide apelin[2].
Diprotin A (TFA)
Diprotin A TFA (Ile-Pro-Ile TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV)[1].
(1r,4r,5r,8r,9s,19r)-4-[(2s)-butan-2-yl]-9-ethyl-4,5,9-trihydroxy-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO9 (455.21552080000004)
2,3-bis(acetyloxy)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl acetate
C26H33NO6 (455.23077580000006)
5-amino-6-[(6-amino-2-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl)oxy]-2-(aminomethyl)oxane-3,4-diol
C17H33N3O11 (455.21149879999996)
(3r,5s)-3-[(2e,4e,6e,8e,10e)-11-[(2r,3r,3as,5s,6as)-3-hydroxy-5-methyl-hexahydrofuro[3,2-b]furan-2-yl]undeca-2,4,6,8,10-pentaenoyl]-5-isopropyl-1-methylpyrrolidine-2,4-dione
C26H33NO6 (455.23077580000006)
(3r)-3-{[(2r,3s,4s,5r)-5-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1,2,3,4,6-pentahydroxyhexylidene]amino}-3-phenylpropanoic acid
C21H33N3O8 (455.22675380000004)
(1r,4r,5s,8r,9s,19r)-9-ethyl-4,5,9-trihydroxy-8-methyl-4-(sec-butyl)-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO9 (455.21552080000004)
2-[(4,6-diamino-3-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl)oxy]oxane-3,4,5-triol
C17H33N3O11 (455.21149879999996)
(2r,3s,4r,5r,6r)-5-amino-6-{[(1r,2r,3s,4r,6s)-6-amino-2-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl]oxy}-2-(aminomethyl)oxane-3,4-diol
C17H33N3O11 (455.21149879999996)
3-({5-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1,2,3,4,6-pentahydroxyhexylidene}amino)-3-phenylpropanoic acid
C21H33N3O8 (455.22675380000004)
4,5,9-trihydroxy-4,9-diisopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO9 (455.21552080000004)
9-ethyl-4,5,9-trihydroxy-8-methyl-4-(sec-butyl)-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO9 (455.21552080000004)
(1s,2s,3s,5r,8r,9s,10r,11s,14r,16s,17r,18r)-2,3-bis(acetyloxy)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl acetate
C26H33NO6 (455.23077580000006)
5-hydroxy-4-[(2e,4e,6e,8e,10e)-11-{3-hydroxy-5-methyl-hexahydrofuro[3,2-b]furan-2-yl}undeca-2,4,6,8,10-pentaenoyl]-2-isopropyl-1-methyl-2h-pyrrol-3-one
C26H33NO6 (455.23077580000006)
(5s)-3-[(2e,4e,6e,8e,10e)-11-[(2s,3r,3ar,5r,6ar)-3-hydroxy-5-methyl-hexahydrofuro[3,2-b]furan-2-yl]-1-hydroxyundeca-2,4,6,8,10-pentaen-1-ylidene]-5-isopropyl-1-methylpyrrolidine-2,4-dione
C26H33NO6 (455.23077580000006)
(3s)-3-{[(2s,3r,4r,5s)-5-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1,2,3,4,6-pentahydroxyhexylidene]amino}-3-phenylpropanoic acid
C21H33N3O8 (455.22675380000004)
3-(11-{3-hydroxy-5-methyl-hexahydrofuro[3,2-b]furan-2-yl}undeca-2,4,6,8,10-pentaenoyl)-5-isopropyl-1-methylpyrrolidine-2,4-dione
C26H33NO6 (455.23077580000006)